The Role of CT-Based Radiomics Nomogram in Differential Diagnosis of Immune Checkpoint Inhibitor-Related Pneumonitis from Radiation Pneumonitis for Patients with ESCC

被引:0
|
作者
Wen, Q. [1 ,2 ]
Yang, Z. [1 ]
Qiu, Q. [3 ]
Xing, L. [4 ]
Li, R. [5 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[2] Stanford Uni, Dept Radiotherapy, Palo Alto, CA USA
[3] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[4] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China
[5] Stanford Univ, Dept Radiat Oncol, Stanford, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2765
引用
收藏
页码:E350 / E351
页数:2
相关论文
共 50 条
  • [41] Characterization of immunomodulatory factors and cells in bronchoalveolar lavage fluid for immune checkpoint inhibitor-related pneumonitis
    Peng-Mei Wang
    Zhong-Wei Zhang
    Shan Zhang
    Qian Xing
    Zhi-Yong Zhao
    Qiong-Hua Lin
    Li-Hua Shen
    Zhi-Li Xia
    Fang-Fang Li
    Biao Zhu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 8019 - 8026
  • [42] Characterization of immunomodulatory factors and cells in bronchoalveolar lavage fluid for immune checkpoint inhibitor-related pneumonitis
    Wang, Peng-Mei
    Zhang, Zhong-Wei
    Zhang, Shan
    Xing, Qian
    Zhao, Zhi-Yong
    Lin, Qiong-Hua
    Shen, Li-Hua
    Xia, Zhi-Li
    Li, Fang-Fang
    Zhu, Biao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 8019 - 8026
  • [43] Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
    Mao, Zhirong
    Pang, Guanchao
    Huang, Xiaojie
    Chen, Xiuxiu
    Wu, Jiaji
    Xu, Xia
    Teng, Zhihua
    Tan, Yanbin
    Wang, Pingli
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [44] Multidisciplinary Approach of Immune Checkpoint Inhibitor-Related Pneumonitis: A Key to Address Knowledge and Management Gaps
    Perol, Maurice
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (08) : 1261 - 1264
  • [45] Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience
    Lin, Xinqing
    Deng, Haiyi
    Chen, Likun
    Wu, Di
    Chen, Xiaobo
    Yang, Yilin
    Chen, Tao
    Xie, Xiaohong
    Xie, Zhanhong
    Liu, Ming
    Ouyang, Ming
    Qin, Yinyin
    Li, Shiyue
    Zhong, Nanshan
    Gregg, Jeffrey P.
    Horita, Nobuyuki
    Song, Yong
    Zhou, Chengzhi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 415 - 429
  • [46] Association of Clinical and Radiological Features with Disease Severity of Symptomatic Immune Checkpoint Inhibitor-Related Pneumonitis
    Zhang, Qian
    Tao, Xiuli
    Zhao, Shijun
    Li, Ning
    Wang, Shuhang
    Wu, Ning
    DIAGNOSTICS, 2023, 13 (04)
  • [47] Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer
    Lin, Xinqing
    Deng, Haiyi
    Yang, Yilin
    Wu, Jianhui
    Qiu, Guihuan
    Li, Suyang
    Xie, Xiaohong
    Liu, Ming
    Xie, Zhanhong
    Qin, Yinyin
    Song, Yong
    Zhou, Chengzhi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] A nomogram model for predicting the risk of checkpoint inhibitor-related pneumonitis for patients with advanced non-small-cell lung cancer
    Zhang, Yao
    Zhang, Lincheng
    Cao, Shuhui
    Wang, Yue
    Ling, Xuxinyi
    Zhou, Yan
    Zhong, Hua
    CANCER MEDICINE, 2023, 12 (15): : 15998 - 16010
  • [49] Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
    Jiafan Liu
    Dongmei Zhou
    Na Wu
    Jia Liu
    Xiaonan Wang
    BMC Geriatrics, 25 (1)
  • [50] Predictive factors and prognosis of immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer patients
    Liu, Xiaoyu
    Hao, Na
    Yang, Shuangning
    Li, Jieyao
    Wang, Liping
    FRONTIERS IN ONCOLOGY, 2023, 13